• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

InterMune

NASDAQ:ITMN

$10.73 $0.54 (5.30%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT

5/24/2012 by StreetInsider.com

InterMune price target lowered to $15 from $24 at Canaccord

5/24/2012 by Theflyonthewall.com

InterMune deal delivers $55M in fresh fuel for fibrosis drug

5/23/2012 by Fierce Biotech

InterMune agrees to sell immune drug Actimmune

5/22/2012 by Product Design and Development

InterMune to Sell Actimmune Rights - Analyst Blog

5/22/2012 by Zacks Investment Research

InterMune to Sell Actimmune Rights

5/22/2012 by Zacks Equity Research Analyst Blog

InterMune's (ITMN) Esbriet Survey Results Favorable - Goldman Sachs

5/22/2012 by StreetInsider.com

InterMune to divest Actimmune, focus deal cash on lung drug

5/22/2012 by East Bay Business Times - Pleasanton CA

InterMune to Divest Actimmune® (Interferon Gamma-1b)

5/21/2012 by PR Newswire

Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Esbriet (pirfenidone) Positive GBA Assessment

5/21/2012 by StreetInsider.com

Publication of PANTHER results a positive for InterMune, says Leerink

5/21/2012 by Theflyonthewall.com

InterMune management to meet with JMP Securities

5/17/2012 by Theflyonthewall.com

JP Morgan's biotech analysts hold a conference call on orphan drug coverage

5/8/2012 by Theflyonthewall.com

The Medicines' CEO Presents at Deutsche Bank Annual Healthcare Conference (Transcript)

5/7/2012 by Seeking Alpha

Esbriet Drives InterMune's Revenue

4/30/2012 by Zacks Equity Research Analyst Blog

Most Active Stocks: American Express, Fusion-IO, Marvell, Johnson & Johnson, Agnico-Eagle Mines, and InterMune

4/30/2012 by PR Newswire

Highs & Lows: Aware, Jazz Pharmaceuticals, and InterMune

4/27/2012 by Schaeffer's Trading Floor Blog

Highs & Lows: Aware, Jazz Pharmaceuticals, and InterMune

4/27/2012 by Schaeffer's Investment Research

Intermune (ITMN) PT Lowered To $33 By Brean Murray As Esbriet Sales Come In Light

4/27/2012 by iStockAnalyst

InterMune breaks below its 10-day MA, support is at $9.99

4/27/2012 by Theflyonthewall.com

Brean Murray Carret & Co. Says Shares of InterMune (ITMN) Undervalued Despite Pressure from Esbriet Sales

4/27/2012 by StreetInsider.com

JMP Securities Downgrades InterMune Inc. (ITMN) to Market Perform

4/27/2012 by StreetInsider.com

InterMune downgraded to Market Perform from Outperform at JMP Securities

4/27/2012 by Theflyonthewall.com

InterMune Q1 Esbriet sales were approximately $4.9M in Europe

4/26/2012 by Theflyonthewall.com

InterMune reports Q1 EPS (74c), consensus (70c)

4/26/2012 by Theflyonthewall.com

InterMune Reports First Quarter 2012 Financial Results And Business Highlights

4/26/2012 by PR Newswire

Biotech names with the highest probability of M&A activity at Goldman

4/23/2012 by Theflyonthewall.com

InterMune sentiment could turn positive, says Brean Murray

4/23/2012 by Theflyonthewall.com

InterMune To Release First Quarter Financial Results On April 26

4/19/2012 by PR Newswire

InterMune added to Most Preferred List at UBS

4/18/2012 by Theflyonthewall.com

Gilead, Alexion, InterMune best biotech ideas into Q1 results at JPMorgan

4/17/2012 by Theflyonthewall.com

UBS Securities Starts Intermune (ITMN) At 'Neutral', $13.50 PT

4/12/2012 by iStockAnalyst

UPDATE - UBS Initiates Coverage on Intermune (ITMN) with a Neutral; Overshot to Downside, But Stuck Until More Clarity

4/12/2012 by StreetInsider.com

InterMune initiated with a Neutral at UBS

4/12/2012 by Theflyonthewall.com

Intermune's Long Slog With Esbriet Shows No Sign Of Quickening

4/11/2012 by Seeking Alpha

Recent Volatility Does Not Affect Long-Term Prospects of InterMune

4/11/2012 by Morningstar

Sectoral Asset Management raises passive stake in InterMune to 10% from 8.8%

4/10/2012 by Theflyonthewall.com

Brean Murray Lowers Price Target On Intermune (ITMN) To $37

4/10/2012 by iStockAnalyst

Brean Murray Carret & Co. Adjusting Estimates & PT InterMune Inc. (ITMN); Timelines Push Things Back

4/10/2012 by StreetInsider.com

Top Stock Alerts for Day Traders: InterMune, Dell, KB Home, Corning, Dangdang, and Mcmoran Exploration

4/10/2012 by PR Newswire
See More Articles...